Sperling Prostate Center

Tag: multiparametric MRI

Artificial Intelligence in Medicine: Reducing False Positives on MRI

No one is perfect, including radiologists who read and interpret multiparametric MRI (mpMRI) prostate scans. However, some are better than others. Studies show that experienced readers are generally more accurate than less experienced readers. In fact, based on the number of MRIs reviewed over time as well as continuing education (conferences, training workshops, classes, etc.), keep reading

Can mpMRI Predict Prostate Cancer Stage?

MRI/Ultrasound Fusion May Come with a Pitfall Called Registration Error
If you are diagnosed with prostate cancer, you want to know, with as much accuracy as possible PSA and its variants - determined by blood test, Gleason score/Gleason Grade Group - determined by biopsy, and clinical stage - determined the old-fashioned way by combination of digital rectal exam or DRE, biopsy, inadequate information from ultrasound, and educated guess... keep reading

Overused Random Biopsies: The Real Culprit

Numerous studies have validated the hypothesis that if mpMRI does not detect significant prostate cancer (PCa), no biopsy is needed; but if a biopsy is indicated, MRI-targeted biopsy overcomes the problems of the TRUS random biopsies. It minimizes the number of needles while maximizing diagnostic accuracy. As one paper states... keep reading

Prostate Cancer: Warnings in the News

Coping with Prostate Cancer
Some people are driven to seek fame, but no one wants to be a prostate cancer celebrity. And yet, as of this writing, a several notables have made recent headlines due to their prostate cancer (PCa). After some initial secrecy, it was revealed that Defense Secretary Lloyd Austin was diagnosed, treated, and re-hospitalized for complications keep reading
WordPress Image Lightbox